Effects of Nebivolol on Microvascular Perfusion in the Skeletal Muscles During Exercise in Hypertensive Patients

Trial Profile

Effects of Nebivolol on Microvascular Perfusion in the Skeletal Muscles During Exercise in Hypertensive Patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jul 2016

At a glance

  • Drugs Nebivolol (Primary) ; Hydrochlorothiazide; Metoprolol succinate
  • Indications Essential hypertension
  • Focus Pharmacodynamics
  • Most Recent Events

    • 02 Dec 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 02 Dec 2014 Planned End Date changed from 1 Aug 2013 to 1 Aug 2015 as reported by ClinicalTrials.gov.
    • 02 Dec 2014 Planned primary completion date changed from 1 Aug 2013 to 1 Aug 2015 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top